Sign in
Active, not recruitingPhase 4

Efficacy of Donepezil in Patients With Chronic Tinnitus

Key facts

Who runs it
University of Sao Paulo
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 4
People taking part
70 people, planned
Started
19 Nov 2021
Ended
9 Dec 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Donepezil group
  • Placebo group
Record updated
4 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • patients with chronic sensorineural tinnitus type

Who cannot take part

  • pregnancy, arrhythmia, donepezil allergy, yelow dye allergy, otitis or any ear inflamatory diseases, patients taking any medication for dementia, convulsive diseases, asthma, patients taking any of these medications: carbamazepine, dexamethasone, phenobarbital, phenytoin, rifampicin, ketoconazole, quinidine

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.

The 2 groups in the trial

  • Intervention Group (donepezil)Treatment being tested

    35 Participants with tinnitus received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.

    Treatment: Donepezil group

  • Placebo groupPlacebo, for comparison

    35 Pacients with tinnitus received for 3 months placebo medication

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
4 September 2025